Weight-Loss Jabs Like Ozempic Reduce Heart Attack Risk by 20%, Study Finds

May 14, 2024, 08:23 AM

A major study has found that weight-loss jabs, such as Ozempic, can significantly reduce the risk of heart attacks and strokes, even in patients who do not lose weight. The study highlights that these anti-obesity jabs cut the risk of heart death by 20%, prompting calls from doctors and the UK’s leading cardiologist for millions of Britons to be prescribed these medications. The jabs are being hailed as the biggest breakthrough since statins, with medics suggesting they should be prescribed similarly to statins to improve cardiovascular health.